Outcomes of allogeneic transplantation with non-myeloablative conditioning in patients with myelodysplastic and overlap syndromes

被引:0
|
作者
Hilali, Ammar [1 ]
Hibbs, Stephen [1 ]
Davies, Jeff [1 ,2 ]
Smith, Matthew [1 ]
机构
[1] Queen Mary Univ London, Barts Hlth Natl Hlth Serv NHS Trust, Dept Haematooncol, London, England
[2] Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, London, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BSH2021-PO
引用
收藏
页码:227 / 228
页数:2
相关论文
共 50 条
  • [1] NON-MYELOABLATIVE CONDITIONING AND ALLOGENEIC TRANSPLANTATION FOR MULTIPLE MYELOMA
    Osman, K.
    Elliott, B.
    Mandeli, J.
    Scigliano, E.
    Ross-Dodds, V.
    Isola, L.
    Grosskreutz, C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 71 - 71
  • [2] Radioimmunotherapy as non-myeloablative conditioning for allogeneic marrow transplantation
    Bethge, Wolfgang A.
    Wilbur, D. Scott
    Sandmaier, Brenda M.
    LEUKEMIA & LYMPHOMA, 2006, 47 (07) : 1205 - 1214
  • [3] Non-myeloablative conditioning and allogeneic transplantation for multiple myeloma
    Osman, Keren
    Elliott, Brian
    Mandeli, John
    Scigliano, Eileen
    Malone, Adriana
    Isola, Luis
    Grosskreutz, Celia
    AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (04) : 249 - 254
  • [4] Comparison of non-myeloablative and reduced-intensity allogeneic stem cell transplantation in older patients with myelodysplastic syndromes
    Jentzsch, Madlen
    Doehring, Christine
    Linke, Richard
    Hille, Andrea
    Grimm, Juliane
    Poenisch, Wolfram
    Vucinic, Vladan
    Franke, Georg-Nikolaus
    Behre, Gerhard
    Niederwieser, Dietger
    Schwind, Sebastian
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (12) : 1344 - 1352
  • [5] Non-myeloablative allogeneic hematopoietic cell transplantation (AHCT) for patients with myelodysplastic syndromes (MDS) and myeloproliferative disorders (MPD).
    Cao, TM
    McSweeney, PA
    Niederwieser, D
    Sahebi, F
    Sandmaier, BM
    Chauncey, TR
    Maris, MB
    Forman, SJ
    Blume, KG
    Shizuru, JA
    Storb, RF
    BLOOD, 2000, 96 (11) : 170A - 170A
  • [6] Myeloablative versus non-myeloablative allogeneic hematopoietic stem cell transplantation for patients with advanced acute myeloid leukemia or myelodysplastic syndromes: A retrospective analysis
    Hong, M. Yoo
    Park, I. H.
    Yoon, S. H.
    Kim, S. J.
    Lee, H. W.
    Hwang, D. Y.
    Kim, Y. R.
    Kim, J. S.
    Cheong, J. W.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 456 - 456
  • [7] Comparison of non-myeloablative and reduced-intensity conditioning prior to allogeneic stem cell transplantation in older patients with myelodysplastic syndrome
    Jentzsch, Madlen
    Pfrepper, Christian
    Linke, Richard
    Doehring, Christine
    Grimm, Juliane
    Beinicke, Stefanie
    Haentschel, Janine
    Hille, Andrea
    Poenisch, Wolfram
    Vucinic, Vladan
    Franke, Georg-Nikolaus
    Behre, Gerhard
    Niederwieser, Dietger
    Schwind, Sebastian
    BONE MARROW TRANSPLANTATION, 2018, 53 : 268 - 269
  • [8] Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies improved outcomes over two decades
    Cooper, Jason P.
    Storer, Barry E.
    Granot, Noa
    Gyurkocza, Boglarka
    Sorror, Mohamed L.
    Chauncey, Thomas R.
    Shizuru, Judith
    Franke, Georg-Nikolaus
    Maris, Michael B.
    Boyer, Michael
    Bruno, Benedetto
    Sahebi, Firoozeh
    Langston, Amelia A.
    Hari, Parameswaran
    Agura, Edward D.
    Petersen, Soren Lykke
    Maziarz, Richard T.
    Bethge, Wolfgang
    Asch, Julie
    Gutman, Jonathan A.
    Olesen, Gitte
    Yeager, Andrew M.
    Hubel, Kai
    Hogan, William J.
    Maloney, David G.
    Mielcarek, Marco
    Martin, Paul J.
    Flowers, Mary E. D.
    Georges, George E.
    Woolfrey, Ann E.
    Deeg, H. Joachim
    Scott, Bart L.
    McDonald, George B.
    Storb, Rainer
    Sandmaier, Brenda M.
    HAEMATOLOGICA, 2021, 106 (06) : 1599 - 1607
  • [9] Non-myeloablative conditioning regimen for allogeneic stem cell transplantation in patients with advanced hematological malignancies
    Malesevic, M
    Stamatovic, D
    Tukic, L
    Marjanovic, S
    Balint, B
    Tarabar, O
    Todoric, B
    Ristic, L
    Milicevic, S
    BONE MARROW TRANSPLANTATION, 2001, 27 : S294 - S295
  • [10] A comparison of non-myeloablative versus reduced conditioning for allogeneic stem cell transplantation
    Ringdén, O
    Le Blanc, K
    Uzunel, M
    Mattsson, J
    Barkholt, L
    Remberger, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S38 - S38